Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature.
Natalia Gallego-ZazoAlejandro Cruz-UtrillaMaría Jesús Del CerroNuria OchoaJulián Nevado BlancoPedro AriasPablo LapunzinaPilar Escribano-SubiasJair Antonio Tenorio CastañoPublished in: Genes (2022)
Pulmonary arterial hypertension (PAH) is a severe clinical condition characterized by an increase in mean pulmonary artery pressure, which leads to a right ventricular hypertrophy and potentially heart failure and death. In the last several years, many genes have been associated with PAH, particularly in idiopathic and heritable forms but also in associated forms. Here we described the identification of two unrelated families in which the AQP1 variant was found from a cohort of 300 patients. The variants were identified by whole exome sequencing (WES). In the first family, the variant was detected in three affected members from a hereditary PAH, and in the second family the proband had PAH associated with scleroderma. In addition, we have reviewed all cases published in the literature thus far of patients with PAH and AQP1 variants. Functional studies have led to some contradictory conclusions, and the evidence of the relationship of AQP1 and PAH is still limited. However, we describe two further families with PAH and variants in AQP1 , expanding both the number of cases and the clinically associated phenotype. We provide further evidence of the association of AQP1 and the development of hereditary and associated forms of PAH.
Keyphrases
- pulmonary arterial hypertension
- pulmonary artery
- polycyclic aromatic hydrocarbons
- pulmonary hypertension
- heart failure
- coronary artery
- copy number
- end stage renal disease
- systematic review
- randomized controlled trial
- newly diagnosed
- peritoneal dialysis
- early onset
- atrial fibrillation
- genome wide
- transcription factor
- prognostic factors
- genome wide identification
- cord blood